個案資料
了解個案內容與學習目標，選擇授課教師及使用課程。
ImmuLogic Pharmaceutical Corp. (A): March 1991
內容大綱
ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The diverse perspectives of the entrepreneur, venture capitalist, investment banker, and institutional investor are explored. Problems of valuation are highlighted. The challenges posed by "windows" for public offerings are considered.